1. Home
  2. ADBT vs CCEL Comparison

ADBT vs CCEL Comparison

Compare ADBT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advasa Holdings Inc. Common Stock

ADBT

Advasa Holdings Inc. Common Stock

N/A

Current Price

$0.08

Market Cap

39.9M

Sector

Technology

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

SELL

Current Price

$4.40

Market Cap

37.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ADBT
CCEL
Founded
2017
1989
Country
Japan
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
37.3M
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
ADBT
CCEL
Price
$0.08
$4.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 3.8M
9.0K
Earning Date
11-20-2026
10-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
0.01
★ 0.23
Revenue
N/A
★ $25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $10.89
$18.04
Revenue Growth
N/A
★ 9.76
52 Week Low
$0.07
$2.72
52 Week High
$4.99
$5.45

Technical Indicators

Market Signals
Indicator
ADBT
CCEL
Relative Strength Index (RSI) 6.62 42.81
Support Level N/A $3.14
Resistance Level $0.13 $4.76
Average True Range (ATR) 0.01 0.39
MACD 0.03 -0.13
Stochastic Oscillator 19.53 8.46

Price Performance

Historical Comparison
ADBT
CCEL

About ADBT Advasa Holdings Inc. Common Stock

Advasa Holdings Inc is a financial technology and services company that offers a suite of financial services and solutions. Its earned wage access (EWA) service, named 'FUKUPE', provides employees with real-time access to their earned wages through cashless receipts and settlements that integrate seamlessly with wallets, cards, and bank accounts. The company also licenses its EWA technology portfolio and offers OEM (original equipment manufacturer) services. The company generates the majority of revenue from the provision of software maintenance services. Geographically, the company operates only in Japan.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: